Allarity Therapeutics Inc (United States) is listed on the Nasdaq and has a market capitalization of $19.09 million, with shareholders equity totaling $3.54 million.
The company employs approximately 15 people and operates in the Others sector, within the Others industry.
Over the past 12 months, Allarity Therapeutics Inc reported $25.00 Thousand in revenue, generating net income of $-12.33 million.
Key financial metrics include a P/E ratio of -1.55, a price-to-book (P/B) ratio of 5.40, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker ALLR.